Karessa Pharma signs cooperation agreement with PlastoPharma for the manufacturing of the drug candidate Vigressa™
Karessa Pharma announces today that the company has signed a cooperation agreement with Laboratories Plasto Santé (PlastoPharma) regarding the manufacturing of pharmaceuticals for the upcoming clinical trial of Vigressa™ - a drug candidate with potential to improve the treatment of impotence. The collaboration with PlastoPharma is also aimed to ensuring a well-functioning and cost-effective manufacturing of Vigressa™ on a commercial scale for future market launch.PlastoPharma is a privately owned contract manufacturer with more than 20 years of experience in transdermal, film-based drugs.